Trial Profile
Retrospective study of eribulin in heavily pretreated patients with advanced breast cancer (BC) in a real-life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Aug 2018 New trial record